Hydroxychloroquine is protective to the heart, not harmful: A systematic review

{ 'indexed': {'date-parts': [[2024, 2, 8]], 'date-time': '2024-02-08T18:00:43Z', 'timestamp': 1707415243619}, 'reference-count': 43, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2020, 9, 1]], 'date-time': '2020-09-01T00:00:00Z', 'timestamp': 1598918400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2020, 8, 19]], 'date-time': '2020-08-19T00:00:00Z', 'timestamp': 1597795200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 9]]}, 'DOI': '10.1016/j.nmni.2020.100747', 'type': 'journal-article', 'created': {'date-parts': [[2020, 8, 20]], 'date-time': '2020-08-20T06:47:02Z', 'timestamp': 1597906022000}, 'page': '100747', 'source': 'Crossref', 'is-referenced-by-count': 13, 'title': 'Hydroxychloroquine is protective to the heart, not harmful: a systematic review', 'prefix': '10.1016', 'volume': '37', 'author': [ {'given': 'C.C.', 'family': 'Prodromos', 'sequence': 'first', 'affiliation': []}, {'given': 'T.', 'family': 'Rumschlag', 'sequence': 'additional', 'affiliation': []}, {'given': 'T.', 'family': 'Perchyk', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.nmni.2020.100747_bib1', 'first-page': '215', 'article-title': '[A pilot study of hydroxychloroquine in treatment of patients with ' 'moderate COVID-19]', 'volume': '49', 'author': 'Chen', 'year': '2020', 'journal-title': 'Zhejiang Da Xue Xue Bao Yi Xue Ban'}, { 'key': '10.1016/j.nmni.2020.100747_bib2', 'doi-asserted-by': 'crossref', 'first-page': '101738', 'DOI': '10.1016/j.tmaid.2020.101738', 'article-title': 'Early treatment of COVID-19 patients with hydroxychloroquine and ' 'azithromycin: a retrospective analysis of 1061 cases in Marseille, ' 'France', 'volume': '35', 'author': 'Million', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '10.1016/j.nmni.2020.100747_bib3', 'series-title': 'Low dose of hydroxychloroquine reduces fatality of critically ill ' 'patients with COVID-19', 'author': 'Yu', 'year': '2020'}, { 'key': '10.1016/j.nmni.2020.100747_bib4', 'series-title': 'Controversial doc in Trump’s ear calls malaria drug study ‘garbage.’ ' 'Daily Beast', 'author': 'Olding', 'year': '2020'}, { 'key': '10.1016/j.nmni.2020.100747_bib5', 'doi-asserted-by': 'crossref', 'first-page': 'e33', 'DOI': '10.1016/j.jaad.2020.04.031', 'article-title': 'Does hydroxychloroquine combat COVID-19? A timeline of evidence', 'volume': '83', 'author': 'Alia', 'year': '2020', 'journal-title': 'J\xa0Am Acad Dermatol'}, { 'key': '10.1016/j.nmni.2020.100747_bib6', 'doi-asserted-by': 'crossref', 'first-page': '493', 'DOI': '10.1111/acem.14005', 'article-title': 'A\xa0rapid systematic review of clinical trials utilizing chloroquine ' 'and hydroxychloroquine as a treatment for COVID-19', 'volume': '27', 'author': 'Chowdhury', 'year': '2020', 'journal-title': 'Acad Emerg Med'}, { 'key': '10.1016/j.nmni.2020.100747_bib7', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofaa130', 'article-title': 'Review: hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 ' '(COVID-19)', 'volume': '7', 'author': 'Pastick', 'year': '2020', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '10.1016/j.nmni.2020.100747_bib10', 'series-title': 'Caution recommended on COVID-19 treatment with hydroxychloroquine and ' 'azithromycin for patients with cardiovascular disease', 'year': '2020'}, { 'key': '10.1016/j.nmni.2020.100747_bib12', 'doi-asserted-by': 'crossref', 'first-page': '736', 'DOI': '10.1136/annrheumdis-2019-215089', 'article-title': '2019 update of the EULAR recommendations for the management of systemic ' 'lupus erythematosus', 'volume': '78', 'author': 'Fanouriakis', 'year': '2019', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.nmni.2020.100747_bib13', 'series-title': 'Ohio pharmacy board restricts prescriptions for experimental coronavirus ' 'treatment drugs. Columbus (Ohio) Dispatch', 'author': 'Sullivan', 'year': '2020'}, { 'key': '10.1016/j.nmni.2020.100747_bib14', 'doi-asserted-by': 'crossref', 'first-page': '363', 'DOI': '10.1097/RHU.0b013e31826852db', 'article-title': 'Fatal antimalarial-induced cardiomyopathy: report of 2 cases', 'volume': '18', 'author': 'Azimian', 'year': '2012', 'journal-title': 'J\xa0Clin Rheumatol'}, { 'key': '10.1016/j.nmni.2020.100747_bib15', 'doi-asserted-by': 'crossref', 'first-page': '336', 'DOI': '10.1016/j.semarthrit.2003.09.012', 'article-title': 'Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a ' 'report of 2 cases and review of the literature', 'volume': '33', 'author': 'Nord', 'year': '2004', 'journal-title': 'Semin Arthritis Rheum'}, { 'key': '10.1016/j.nmni.2020.100747_bib16', 'doi-asserted-by': 'crossref', 'first-page': '286', 'DOI': '10.1097/RHU.0b013e31829d5e50', 'article-title': 'Suspected hydroxychloroquine-associated QT-interval prolongation in a ' 'patient with systemic lupus erythematosus', 'volume': '19', 'author': 'Morgan', 'year': '2013', 'journal-title': 'J\xa0Clin Rheumatol'}, { 'key': '10.1016/j.nmni.2020.100747_bib17', 'first-page': '4626279', 'article-title': 'Life threatening severe QTc prolongation in patient with systemic lupus ' 'erythematosus due to hydroxychloroquine', 'volume': '2016', 'author': 'O’Laughlin', 'year': '2016', 'journal-title': 'Case Rep Cardiol'}, { 'key': '10.1016/j.nmni.2020.100747_bib18', 'doi-asserted-by': 'crossref', 'first-page': '173', 'DOI': '10.1080/15563650500514558', 'article-title': 'Chronic hydroxychloroquine use associated with QT prolongation and ' 'refractory ventricular arrhythmia', 'volume': '44', 'author': 'Chen', 'year': '2006', 'journal-title': 'Clin Toxicol (Phila)'}, { 'key': '10.1016/j.nmni.2020.100747_bib19', 'doi-asserted-by': 'crossref', 'first-page': '79', 'DOI': '10.4269/ajtmh.20-0376', 'article-title': 'Case report: right bundle brunch block and QTc prolongation in a ' 'patient with novel coronavirus disease (COVID-19) treated with ' 'hydroxychloroquine', 'volume': '103', 'author': 'Asli', 'year': '2020', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '10.1016/j.nmni.2020.100747_bib20', 'doi-asserted-by': 'crossref', 'first-page': '924', 'DOI': '10.1093/rheumatology/41.8.924', 'article-title': 'A\xa0cross-sectional study of clinical thrombotic risk factors and ' 'preventive treatments in antiphospholipid syndrome', 'volume': '41', 'author': 'Erkan', 'year': '2002', 'journal-title': 'Rheumatology (Oxford)'}, { 'key': '10.1016/j.nmni.2020.100747_bib21', 'doi-asserted-by': 'crossref', 'first-page': '76', 'DOI': '10.1161/CIRCULATIONAHA.111.089268', 'article-title': 'Maternal use of hydroxychloroquine is associated with a reduced risk of ' 'recurrent anti-SSA/Ro-antibody–associated cardiac manifestations of ' 'neonatal lupus', 'volume': '126', 'author': 'Izmirly', 'year': '2012', 'journal-title': 'Circulation'}, { 'key': '10.1016/j.nmni.2020.100747_bib22', 'doi-asserted-by': 'crossref', 'first-page': '254', 'DOI': '10.1016/0002-9343(94)90151-1', 'article-title': 'Effect of prednisone and hydroxychloroquine on coronary artery disease ' 'risk factors in systemic lupus erythematosus: a longitudinal data ' 'analysis', 'volume': '96', 'author': 'Petri', 'year': '1994', 'journal-title': 'Am J Med'}, { 'key': '10.1016/j.nmni.2020.100747_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1111/ijcp.13095', 'article-title': 'Hydroxychloroquine may be associated with reduced risk of coronary ' 'artery diseases in patients with rheumatoid arthritis: a nationwide ' 'population-based cohort study', 'volume': '72', 'author': 'Hung', 'year': '2018', 'journal-title': 'Int J Clin Pract'}, { 'key': '10.1016/j.nmni.2020.100747_bib24', 'series-title': 'Paper presented at: 2019 American college of Rheumatology ' '(ACR)/Association of Rheumatology professionals (ARP) annual meeting; ' '8–13 November 2019; Atlanta, GA. Abstract 2783', 'article-title': 'Hydroxychloroquine blood levels and risk of thrombotic events in ' 'systemic lupus erythematosus', 'author': 'Konig', 'year': '2019'}, { 'key': '10.1016/j.nmni.2020.100747_bib25', 'doi-asserted-by': 'crossref', 'first-page': '577', 'DOI': '10.1177/0961203306071872', 'article-title': 'Effect of antimalarials on thrombosis and survival in patients with ' 'systemic lupus erythematosus', 'volume': '15', 'author': 'Ruiz-Irastorza', 'year': '2006', 'journal-title': 'Lupus'}, { 'key': '10.1016/j.nmni.2020.100747_bib26', 'doi-asserted-by': 'crossref', 'first-page': '34', 'DOI': '10.1111/j.1753-5174.2009.00019.x', 'article-title': 'Drugs used in the treatment of rheumatoid arthritis: relationship ' 'between current use and cardiovascular risk factors', 'volume': '2', 'author': 'Rho', 'year': '2009', 'journal-title': 'Arch Drug Inf'}, { 'key': '10.1016/j.nmni.2020.100747_bib27', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/cpt.1968', 'article-title': 'QT interval prolongation under hydroxychloroquine/azithromycin ' 'association for inpatients with SARS-CoV-2 lower respiratory tract ' 'infection', 'author': 'Bun', 'year': '2020', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': '10.1016/j.nmni.2020.100747_bib28', 'doi-asserted-by': 'crossref', 'DOI': '10.1161/CIRCEP.120.008662', 'article-title': 'The effect of chloroquine, hydroxychloroquine and azithromycin on the ' 'corrected QT interval in patients with SARS-CoV-2 infection', 'volume': '13', 'author': 'Saleh', 'year': '2020', 'journal-title': 'Circ Arrhythm Electrophysiol'}, { 'key': '10.1016/j.nmni.2020.100747_bib29', 'doi-asserted-by': 'crossref', 'first-page': 'R151', 'DOI': '10.1186/ar2045', 'article-title': 'Disease-modifying antirheumatic drugs are associated with a reduced ' 'risk for cardiovascular disease in patients with rheumatoid arthritis: ' 'a case control study', 'volume': '8', 'author': 'Van Halm', 'year': '2006', 'journal-title': 'Arthritis Res Ther'}, { 'key': '10.1016/j.nmni.2020.100747_bib30', 'article-title': 'Hydroxychloroquine use is associated with decreased incident ' 'cardiovascular events in rheumatoid arthritis patients', 'volume': '5', 'author': 'Sharma', 'year': '2016', 'journal-title': 'J\xa0Am Heart Assoc'}, { 'key': '10.1016/j.nmni.2020.100747_bib31', 'first-page': '796', 'article-title': 'Long-term hydroxychloroquine therapy and risk of coronary artery ' 'disease in patients with systemic lupus erythematosus', 'volume': '8', 'author': 'Yang', 'year': '2019', 'journal-title': 'J\xa0Clin Med'}, { 'key': '10.1016/j.nmni.2020.100747_bib32', 'doi-asserted-by': 'crossref', 'first-page': '6615', 'DOI': '10.18632/oncotarget.23570', 'article-title': 'The association between hydroxychloroquine treatment and cardiovascular ' 'morbidity among rheumatoid arthritis patients', 'volume': '9', 'author': 'Shapiro', 'year': '2017', 'journal-title': 'Oncotarget'}, { 'key': '10.1016/j.nmni.2020.100747_bib33', 'series-title': 'Paper presented at: 2018 American College of Rheumatology ' '(ACR)/Association of Rheumatology Professionals (ARP) annual meeting; ' '19–24 October 2018; Chicago, IL. Abstract 2670', 'article-title': 'Association of hydroxychloroquine use and incident atrial fibrillation ' 'in systemic lupus erythematosus: a retrospective study', 'author': 'Gupta', 'year': '2018'}, { 'key': '10.1016/j.nmni.2020.100747_bib34', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamacardio.2020.1834', 'article-title': 'Risk of QT interval prolongation associated with use of ' 'hydroxychloroquine with or without concomitant azithromycin among ' 'hospitalized patients testing positive for coronavirus disease 2019 ' '(COVID-19)', 'author': 'Mercuro', 'year': '2020', 'journal-title': 'JAMA Cardiol'}, { 'key': '10.1016/j.nmni.2020.100747_bib35', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.hrthm.2020.06.029', 'article-title': 'Effects of hydroxychloroquine treatment on QT interval', 'author': 'Hooks', 'year': '2020', 'journal-title': 'Heart Rhythm'}, { 'key': '10.1016/j.nmni.2020.100747_bib36', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.hrthm.2020.05.014', 'article-title': 'QT interval prolongation and torsade de pointes in patients with ' 'COVID-19 treated with hydroxychloroquine/azithromycin', 'author': 'Chorin', 'year': '2020', 'journal-title': 'Heart Rhythm'}, { 'key': '10.1016/j.nmni.2020.100747_bib37', 'doi-asserted-by': 'crossref', 'first-page': '1685', 'DOI': '10.2147/DDDT.S166893', 'article-title': 'Chloroquine and hydroxychloroquine are associated with reduced ' 'cardiovascular risk: a systematic review and meta-analysis', 'volume': '12', 'author': 'Liu', 'year': '2018', 'journal-title': 'Drug Des Devel Ther'}, { 'key': '10.1016/j.nmni.2020.100747_bib38', 'doi-asserted-by': 'crossref', 'first-page': '98', 'DOI': '10.1136/annrheumdis-2017-211836', 'article-title': 'Metabolic and cardiovascular benefits of hydroxychloroquine in patients ' 'with rheumatoid arthritis: a systematic review and meta-analysis', 'volume': '77', 'author': 'Rempenault', 'year': '2018', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.nmni.2020.100747_bib39', 'doi-asserted-by': 'crossref', 'first-page': 'e65', 'DOI': '10.1136/annrheumdis-2017-212571', 'article-title': 'Cardiovascular effects of hydroxychloroquine: a systematic review and ' 'meta-analysis', 'volume': '77', 'author': 'Mathieu', 'year': '2018', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.nmni.2020.100747_bib40', 'series-title': 'Myth-busting: azithromycin does not cause torsade de pointes or increase ' 'mortality. PulmCrit (EMCrit)', 'author': 'Farkas', 'year': '2015'}, { 'key': '10.1016/j.nmni.2020.100747_bib41', 'doi-asserted-by': 'crossref', 'first-page': '232', 'DOI': '10.1007/s12012-014-9289-4', 'article-title': 'Azithromycin can prolong QT interval and suppress ventricular ' 'contraction, but will not induce torsade de pointes', 'volume': '15', 'author': 'Ohara', 'year': '2015', 'journal-title': 'Cardiovasc Toxicol'}, { 'key': '10.1016/j.nmni.2020.100747_bib42', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0200474', 'article-title': 'Azithromycin therapy reduces cardiac inflammation and mitigates adverse ' 'cardiac remodeling after myocardial infarction: potential therapeutic ' 'targets in ischemic heart disease', 'volume': '13', 'author': 'Al-Darraji', 'year': '2018', 'journal-title': 'PLoS One'}, {'key': '10.1016/j.nmni.2020.100747_bib43', 'author': 'Swank'}, { 'key': '10.1016/j.nmni.2020.100747_bib44', 'doi-asserted-by': 'crossref', 'first-page': '1343', 'DOI': '10.1046/j.1538-7836.2003.00261.x', 'article-title': 'Inflammation and thrombosis', 'volume': '1', 'author': 'Esmon', 'year': '2003', 'journal-title': 'J\xa0Thromb Haemost'}, { 'key': '10.1016/j.nmni.2020.100747_bib45', 'doi-asserted-by': 'crossref', 'first-page': '155', 'DOI': '10.1038/s41584-020-0372-x', 'article-title': 'Mechanisms of action of hydroxychloroquine and chloroquine: ' 'implications for rheumatology', 'volume': '16', 'author': 'Schrezenmeier', 'year': '2020', 'journal-title': 'Nat Rev Rheumatol'}, { 'key': '10.1016/j.nmni.2020.100747_bib46', 'doi-asserted-by': 'crossref', 'first-page': '358', 'DOI': '10.1016/j.autrev.2014.12.006', 'article-title': 'Hydroxychloroquine as an antithrombotic in antiphospholipid syndrome', 'volume': '14', 'author': 'Belizna', 'year': '2015', 'journal-title': 'Autoimmun Rev'}], 'container-title': 'New Microbes and New Infections', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2052297520300998?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2052297520300998?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 10, 9]], 'date-time': '2020-10-09T00:04:48Z', 'timestamp': 1602201888000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2052297520300998'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 9]]}, 'references-count': 43, 'alternative-id': ['S2052297520300998'], 'URL': 'http://dx.doi.org/10.1016/j.nmni.2020.100747', 'relation': {}, 'ISSN': ['2052-2975'], 'subject': [], 'container-title-short': 'New Microbes and New Infections', 'published': {'date-parts': [[2020, 9]]}, 'article-number': '100747'}